The Drug Controller General of India on Sunday granted permission to the Serum Institute of India in Pune to conduct phase two and three human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca, PTI reported. Read the full story at Scroll.in

CMC Vellore Announces New Medical College with $60 Million Commitment from the Azim Premji Foundation
We are thrilled to congratulate Christian Medical College (CMC) Vellore on the monumental $60 million commitment from the Azim Premji Foundation to build a new medical college at the Chittoor